186 related articles for article (PubMed ID: 8096746)
1. Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
Pratt CB; Meyer WH; Rao BN; Parham DM; Fleming ID
Cancer Treat Res; 1993; 62():323-6. PubMed ID: 8096746
[No Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Graham-Pole J; Ayass M; Cassano W; Dickson N; Enneking W; Heare M; Heare T; Marcus R; Saleh R; Spanier S
Cancer Treat Res; 1993; 62():339-46. PubMed ID: 8096749
[No Abstract] [Full Text] [Related]
3. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
[No Abstract] [Full Text] [Related]
4. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Delepine N; Delepine G; Desbois JC
Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092
[No Abstract] [Full Text] [Related]
5. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Ekert H; Tiedemann K
Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
[No Abstract] [Full Text] [Related]
6. Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Kalifa C; Razafindrakoto H; Vassal G; Contesso G; Vanel D; Edeline V; Valteau D; Lemerle J
Cancer Treat Res; 1993; 62():347-9. PubMed ID: 7682093
[No Abstract] [Full Text] [Related]
7. Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
Burgers JM
Cancer Treat Res; 1993; 62():173-5. PubMed ID: 8096730
[No Abstract] [Full Text] [Related]
8. An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma.
Rosen G
Cancer Treat Res; 1993; 62():49-54. PubMed ID: 8096759
[No Abstract] [Full Text] [Related]
9. Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
Miser JS; Pritchard DJ; Rock MG; Shives TC; Gilchrist GS; Smithson WA; Arndt CA; Edmonson JH; Schaid DJ
Cancer Treat Res; 1993; 62():333-8. PubMed ID: 8096748
[No Abstract] [Full Text] [Related]
10. The multi-institutional osteosarcoma study: an update.
Link MP
Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
[No Abstract] [Full Text] [Related]
11. Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Miser JS; Krailo M
Cancer Treat Res; 1993; 62():287-91. PubMed ID: 7682089
[No Abstract] [Full Text] [Related]
12. An update of Scandinavian studies of osteosarcoma.
Elomaa I
Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
[No Abstract] [Full Text] [Related]
13. Results of therapy in osteosarcoma: experience in childrens hospitals in Buenos Aires.
Schvartzman E; Scopinaro M; Muriel FS
Cancer Treat Res; 1993; 62():351-3. PubMed ID: 8096750
[No Abstract] [Full Text] [Related]
14. [Results of the treatment of osteosarcoma at the National Children's Hospital of Costa Rica].
Brenes-Sáenz A; Lobo-Sanahuja F; García I; Vargas G; Orlich F
Bol Med Hosp Infant Mex; 1986 Sep; 43(9):544-9. PubMed ID: 3466600
[No Abstract] [Full Text] [Related]
15. Update of osteosarcoma in Ramathibodi, Thailand.
Sirikulchayanonta V; Pochanugool L; Subhadrabandhu T
Cancer Treat Res; 1993; 62():371-4. PubMed ID: 8096752
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy for osteosarcoma: a decade of experience.
Goorin AM; Frei E; Abelson HT
Surg Clin North Am; 1981 Dec; 61(6):1379-89. PubMed ID: 6976007
[No Abstract] [Full Text] [Related]
17. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
[TBL] [Abstract][Full Text] [Related]
18. Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma.
Bacci G; Ferrari S; Longhi A; Forni C; Ruggieri P; Briccoli A; De Paolis M; Setola E
J Clin Oncol; 2003 Dec; 21(24):4662-3. PubMed ID: 14673070
[No Abstract] [Full Text] [Related]
19. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
Tomer G; Cohen IJ; Kidron D; Katz K; Yosipovitch Z; Meller I; Zaizov R
Int J Oncol; 1999 Jul; 15(1):179-85. PubMed ID: 10375613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
